Apyx Medical (APYX) Share-based Compensation (2010 - 2026)

Apyx Medical (APYX) has reported Share-based Compensation for 17 consecutive years, with $8.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 4.22% year-over-year to $8.2 million; the trailing twelve-month figure through Jun 2026 stood at $8.2 million (down 4.22% YoY), and the FY2025 full-year result was $7.6 million, down 0.77% from the prior year.
• Share-based Compensation climbed to $8.2 million in Q2 2026 per APYX's latest filing, from $7.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $8.6 million in Q2 2025 and bottomed at $197000.0 in Q4 2023.
• Historically, Share-based Compensation has averaged $3.5 million across 5 years, with a median of $1.6 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Share-based Compensation tumbled 88.0% in 2023, then jumped 717.25% in 2025.
• Over 5 years, Share-based Compensation stood at $1.6 million in 2022, then sank by 88.0% to $197000.0 in 2023, then surged by 325.38% to $838000.0 in 2024, then tumbled by 40.33% to $500000.0 in 2025, then soared by 1543.85% to $8.2 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $8.2 million, $7.4 million, and $500000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.